8.53 USD
↗ 0.13 (1.55%)AT CLOSE (11:59 AM EDT)
PUMA BIOTECHNOLOGY INC
PBYINASDAQ • USD
8.52
↘ 0.01 (0.06%)
POST MARKET (AS OF 04:15 PM EDT)
Post Market
AS OF 04:15 PM EDT
8.52
↘ 0.01 (0.06%)
Market: CLOSED
PUMA BIOTECHNOLOGY INC (PBYI) trades at $8.53 per share. Technicals currently rate "Strong Buy" while our fundamental analysis reads "Neutral". This is driven by a concerning Altman Z-Score in the distress zone, a bullish Golden Cross on the moving averages and bullish moving average alignment. Valuation metrics suggest PBYI is trading at a discount to its peers, earning an "Attractively Valued" rating.
Technical & fundamental data as of Jul 17, 2026.
Open?$8.28
High?$8.64
Low?$8.25
Prev. Close?$8.40
Volume?256.3K
Avg. Volume?336.0K
VWAP?$8.53
Rel. Volume?0.76x
Bid / Ask
Bid?$7.36 × 100
Ask?$9.69 × 100
Spread?$2.33
Midpoint?$8.53
Valuation & Ratios
Market Cap?427.6M
Shares Out?50.9M
Float?38.1M
Float %?75.5%
P/E Ratio?17.53
P/B Ratio?3.33
EPS?$0.48
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes inventive products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also, it is developing Alisertib, a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis, resulting in apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.
Employees
179
Market Cap
427.6M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2012-03-21
Address
10880 WILSHIRE BLVD.
LOS ANGELES, CA 90024
Phone: (424) 248-6500
LOS ANGELES, CA 90024
Phone: (424) 248-6500
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+3/3)
Medium-Term (Wave)?▲ Bullish(+3/3)
Short-Term (Ripple)?▲ Bullish(+2/3)
MA Alignment?Golden Alignment
Full Technical Analysis →Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?40
Z-Score?0
Momentum?97
Short Sent.?34
Piotroski F-Score?4/9Mixed
Altman Z-Score?-3.18Distress
Confidence?51%Low
Short InterestHigh
Short % of Float?9.53%Elevated
Short Interest?3.6M
Days to Cover?8.5
Free Float38.1M
Avg Daily Volume428.4K
Settlement Date2026-06-30
Financial Health
Current Ratio?2.35Strong
Quick Ratio?2.20Strong
Cash Ratio?0.61Adequate
Debt/Equity?0.09Low
ValuationATTRACTIVELY VALUEDvs 3 peers + S&P 500
Score94/100
P/E?17.5CHEAP▾
Peers50
S&P73
P/B?3.33FAIR▾
Peers50
S&P51
P/S?1.88CHEAP▾
Peers100
S&P69
P/FCF?8.0CHEAP▾
Peers100
S&P93
EV/EBITDA?10.0CHEAP▾
Peers50
S&P81
EV/Sales?1.77CHEAP▾
Peers100
S&P79
Returns & Efficiency
ROE?19.0%STRONG▾
Peers50
S&P64
ROA?12.7%STRONG▾
Peers50
S&P82
Cash Flow & Enterprise
FCF?$53.6M
Enterprise Value?$402.6M
Fundamentals ratios updated end of day